Why the study?
Does cardioneuroablation prevent syncope in patients with neurally mediated reflex syncope?
Does cardioneuroablation prevent syncope in patients with neurally mediated reflex syncope?
Cardioneuroablation appears to be a highly effective and safe potential alternative to pacemaker implantation for carefully selected patients with neurally mediated reflex syncope, though randomized trials are needed.
Answers are grounded in this paper and cite their sources.
Cardioneuroablation may offer alternative to pacing in selected reflex syncope; leaves open confirmation in randomized trials.
OBJECTIVE: An imbalance between parasympathetic and sympathetic tone is a main cause of neurally mediated reflex syncope (NMRS). These patients may be very symptomatic and the condition may require cardiac pacemaker implantation. Cardioneuroablation (CNA) is a relatively novel technique based on radiofrequency ablation of vagal ganglia that can be used in treatment of NMRS. The aim of this analysis was to compare potential role of CNA in patients with NMRS. METHODS: In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Statement, literature search was conducted using the keywords "cardioneuroablation," "vagal denervation," "reflex syncope," "vagal ablation," and "ganglionic plexi ablation." Retrieved citations were first screened independently by 2 reviewers for inclusion and exclusion criteria. RESULTS: Freedom from syncope and freedom from prodrome were 100% and between 50% and 100%, respectively, in the studies. Ablation was performed via both atria in 3 studies; only left atrial approach was used in the remaining studies. There was no major complication related to the procedure reported. CONCLUSION: Focused or extensive vagal ganglia ablation may be a potential alternative to pacemaker implantation in a carefully selected patient population. In contrast to pharmacological therapy and pacemaker implantation, ganglia ablation is designed to get to the root of the problem: disturbances in the intrinsic cardiac autonomic nervous system. This novel technique should be evaluated in large-scale, randomized, controlled trials.
No takes yet. Share an insight, caveat, or question.
Tolga Aksu (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: